Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC
Authors:
Open Access
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 31 (4) , 107568
Abstract
No abstract availableKeywords
Funding Information
- Fritz Thyssen Stiftung
- Deutsche Forschungsgemeinschaft
- Deutsche Forschungsgemeinschaft
This publication has 55 references indexed in Scilit:
- EMT Subtype Influences Epithelial Plasticity and Mode of Cell MigrationDevelopmental Cell, 2018
- Protein kinase A can block EphA2 receptor–mediated cell repulsion by increasing EphA2 S897 phosphorylationMolecular Biology of the Cell, 2016
- EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung CancerCancer Research, 2016
- Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLCJournal of Clinical Investigation, 2014
- Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancerJournal of Clinical Investigation, 2013
- Ephs and ephrins in cancer: Ephrin-A1 signallingSeminars in Cell & Developmental Biology, 2012
- Expression of the Receptor Tyrosine Kinase EphA2 Is Increased in Smokers and Predicts Poor Survival in Non–Small Cell Lung CancerClinical Cancer Research, 2009
- Modes of resistance to anti-angiogenic therapyNature Reviews Cancer, 2008
- Tumorigenesis and the angiogenic switchNature Reviews Cancer, 2003
- Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivoOncogene, 2002